LUKANEX

Antiasthmatic

Montelukast

Composition

Each chewable tablet contains:
Montelukast sodium: 4 mg
Excipients q.s.

Montelukast sodium: 5 mg
Excipients q.s.

Each coated tablet contains:
Montelukast: 10 mg
Excipients q.s.

Each sachet contains:
Montelukast: 4 mg
Excipients q.s.

Presentations

4 mg granulated Lukanex: 40 sachets pack
4 mg Lukanex chewable tablets: 40 chewable tablet pack
5 mg Lukanex chewable tablets: 40 chewable tablet pack
10 mg Lukanex coated tablets: 40 coated tablets pack

Indications

Montelukast is indicated in:
- Prophylaxis and chronic treatment of asthma in adults and pediatric patients from 12 months of age
- Prevention of exercise-induced bronchoconstriction in adult and adolescent patients older than 15 years of age
- Relief of symptoms of seasonal allergic rhinitis in adult and adolescent patients from 2 years of age
- Relief of symptoms of perennial allergic rhinitis in adult patients and children form 6 months of age